These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 18161394

  • 21. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI, Norman SA, Reynolds RG, Gleason PP.
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [Abstract] [Full Text] [Related]

  • 22. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D.
    Raebel MA, Delate T, Ellis JL, Bayliss EA.
    Med Care; 2008 Oct; 46(10):1116-22. PubMed ID: 18815534
    [Abstract] [Full Text] [Related]

  • 23. Assessing the impact of coverage gaps in the Medicare Part D drug benefit.
    Hudson N.
    Find Brief; 2008 Apr; 11(3):1-3. PubMed ID: 18441611
    [Abstract] [Full Text] [Related]

  • 24. Characteristics of Medicare Part D beneficiaries who reach the drug benefit threshold in both of the first two years of the Part D benefit.
    Bayliss EA, Ellis JL, Delate T, Steiner JF, Raebel MA.
    Med Care; 2010 Mar; 48(3):267-72. PubMed ID: 20125044
    [Abstract] [Full Text] [Related]

  • 25. Who will be denied Medicare prescription drug subsidies because of the asset test?
    Rice T, Desmond K.
    Am J Manag Care; 2006 Jan; 12(1):46-54. PubMed ID: 16402888
    [Abstract] [Full Text] [Related]

  • 26. The use of disease-modifying agents among multiple sclerosis patients enrolled in medicare from 1995 to 2002 and the impact of medicare part D: analysis of claims data from the medicare current beneficiary survey.
    Lundy J, Craig BM.
    Clin Ther; 2006 Jan; 28(1):140-5. PubMed ID: 16490588
    [Abstract] [Full Text] [Related]

  • 27. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI, Chertow GM.
    BMC Nephrol; 2006 Jul 06; 7():11. PubMed ID: 16824211
    [Abstract] [Full Text] [Related]

  • 28. Should healthy Medicare beneficiaries postpone enrollment in Medicare Part D?
    Atherly A, Dowd B.
    Health Econ; 2009 Aug 06; 18(8):921-31. PubMed ID: 18972327
    [Abstract] [Full Text] [Related]

  • 29. Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit.
    Stuart B, Briesacher BA, Shea DG, Cooper B, Baysac FS, Limcangco MR.
    Health Aff (Millwood); 2005 Aug 06; 24(4):1022-31. PubMed ID: 16012142
    [Abstract] [Full Text] [Related]

  • 30. Medicare Part D--the sea of choices meets the donut hole.
    Flaer PJ, Dondériz A, Younis MZ.
    J Health Care Finance; 2007 Aug 06; 34(1):1-7. PubMed ID: 18972980
    [Abstract] [Full Text] [Related]

  • 31. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS, Weller W, Hannan E.
    J Health Hum Serv Adm; 2007 Aug 06; 30(1):50-74. PubMed ID: 17557696
    [Abstract] [Full Text] [Related]

  • 32. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP, Sussman J, Massachusettes Health Policy Forum, Massachusetts Medicaid Policy Institute.
    Issue Brief (Mass Health Policy Forum); 2007 May 30; (32):1-32. PubMed ID: 17546802
    [Abstract] [Full Text] [Related]

  • 33. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.
    Neuman P, Strollo MK, Guterman S, Rogers WH, Li A, Rodday AM, Safran DG.
    Health Aff (Millwood); 2007 May 30; 26(5):w630-43. PubMed ID: 17711865
    [Abstract] [Full Text] [Related]

  • 34. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.
    Yin W, Basu A, Zhang JX, Rabbani A, Meltzer DO, Alexander GC.
    Ann Intern Med; 2008 Feb 05; 148(3):169-77. PubMed ID: 18180465
    [Abstract] [Full Text] [Related]

  • 35. Coverage for mental health treatment: do the gaps still persist?
    Zuvekas SH, Meyerhoefer CD.
    J Ment Health Policy Econ; 2006 Sep 05; 9(3):155-63. PubMed ID: 17031020
    [Abstract] [Full Text] [Related]

  • 36. Should healthy Medicare beneficiaries postpone enrollment in Part D?
    Federowicz M.
    Find Brief; 2008 Nov 05; 11(9):1-4. PubMed ID: 19035030
    [Abstract] [Full Text] [Related]

  • 37. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
    De Natale ML.
    Policy Polit Nurs Pract; 2007 Aug 05; 8(3):170-81. PubMed ID: 18178923
    [Abstract] [Full Text] [Related]

  • 38. Factors affecting demand among older adults for medication therapy management services.
    Brooks JM, Unni EJ, Klepser DG, Urmie JM, Farris KB, Doucette WR.
    Res Social Adm Pharm; 2008 Dec 05; 4(4):309-19. PubMed ID: 19064238
    [Abstract] [Full Text] [Related]

  • 39. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.
    Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP.
    Med Care; 2010 May 05; 48(5):409-17. PubMed ID: 20393360
    [Abstract] [Full Text] [Related]

  • 40. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.
    Stuart B, Doshi JA, Briesacher B, Wrobel MV, Baysac F.
    Clin Ther; 2004 Oct 05; 26(10):1688-99. PubMed ID: 15598486
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.